EP Patent

EP0278174A2 — Use of fluticasone propionate in the preparation of a pharmaceutical composition for the treatment of bowel diseases

Assigned to Glaxo Group Ltd · Expires 1988-08-17 · 38y expired

What this patent protects

Use of fluticasone propionate in the treatment of bowel diseases when administered by the oral, stomal or rectal routes.

USPTO Abstract

Use of fluticasone propionate in the treatment of bowel diseases when administered by the oral, stomal or rectal routes.

Drugs covered by this patent

methylphenidate-hydrochloride (METHYLPHENIDATE HYDROCHLORIDE)

Patent Metadata

Patent number: EP0278174A2
Jurisdiction: EP
Classification: —
Expires: 1988-08-17
Drug substance claim: No
Drug product claim: No
Assignee: Glaxo Group Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.